Country websites:


The medical device and therapy related information on this website is aimed exclusively at healthcare professionals.

Not all products are cleared or available for sale in all countries.

By clicking on the button "Accepted and Confirmed" you assure that you have taken note of this information and that you are a healthcare professional.

Fluid management for hemodialysis

Silhouette of a transparent-blue man

Effective cardioprotection

  • Reduced mortality1
  • Reduction of intradialytic hypotensive episodes2
  • Cost-saving potential

Advanced fluid management for effective cardioprotection

Cost-saving potential of fluid management

BCM-Body Composition Monitor

From technology to therapy

The BCM - Body Composition Monitor separates excess fluid (over-hydration) from the lean and adipose tissue components of the body on the basis of a unique body composition model.  

Guiding the hemodialysis patient on the safe path between volume overload and dehydration can be difficult in daily clinical practice.

  • Assessment of fluid status based on subjective indicators has been a limiting factor due to the lack of objectiveness
  • Several other methods that have been proposed are often unavailable, expensive or difficult to handle
  • Most importantly, they are unable to quantify fluid overload or deficiency

The BCM-Body Composition Monitor is the only body composition device specifically designed for the use in patients with ESRD and is the cornerstone of the Advanced Fluid Management therapy program of Fresenius Medical Care. It measures and quantifies key fluid and nutritional parameters and provides a reliable decision basis for fluid and nutritional management of dialysis patients.

The BCM-Body Composition Monitor measures noninvasively, fast and cost-effectively at the bedside.

Related content

1 Wizemann V. et al., Nephrology Dialysis Transplantation (2009); 24: 1574-1579.
2 Machek P. et al., Nephrology Dialysis Transplantation (2010); 25: 538-544.
3 Arneson T. et al., Clinical Journal of the American Society of Nephrology (2010); 5: 1054-1063.
4 Arneson T. et al., Clinical Journal of the American Society of Nephrology (2010); 5: 1054-1063.